HADDOCK2P2I: A Biophysical Model for Predicting the Binding Affinity of Protein–Protein Interaction Inhibitors
暂无分享,去创建一个
Alexandre M. J. J. Bonvin | João P. G. L. M. Rodrigues | Panagiotis L. Kastritis | P. Kastritis | J. Rodrigues | A. Bonvin
[1] C. Dominguez,et al. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.
[2] Philippe Roche,et al. 2P2Idb: a structural database dedicated to orthosteric modulation of protein–protein interactions , 2012, Nucleic Acids Res..
[3] Asher Mullard,et al. Protein–protein interaction inhibitors get into the groove , 2012, Nature Reviews Drug Discovery.
[4] Alexandre M J J Bonvin,et al. Molecular origins of binding affinity: seeking the Archimedean point. , 2013, Current opinion in structural biology.
[5] Wim F Vranken,et al. ACPYPE - AnteChamber PYthon Parser interfacE , 2012, BMC Research Notes.
[6] A. Bonvin,et al. The HADDOCK web server for data-driven biomolecular docking , 2010, Nature Protocols.
[7] B. Villoutreix,et al. A leap into the chemical space of protein-protein interaction inhibitors. , 2012, Current pharmaceutical design.
[8] K. P. Murphy,et al. Thermodynamics of structural stability and cooperative folding behavior in proteins. , 1992, Advances in protein chemistry.
[9] Philippe Roche,et al. Atomic Analysis of Protein-Protein Interfaces with Known Inhibitors: The 2P2I Database , 2010, PloS one.
[10] P. Colman,et al. BCL-2 family antagonists for cancer therapy , 2008, Nature Reviews Drug Discovery.
[11] Alexander D. MacKerell,et al. Computational identification of inhibitors of protein-protein interactions. , 2007, Current topics in medicinal chemistry.
[12] Alexandre M J J Bonvin,et al. Are scoring functions in protein-protein docking ready to predict interactomes? Clues from a novel binding affinity benchmark. , 2010, Journal of proteome research.
[13] Luhua Lai,et al. SCORE: A New Empirical Method for Estimating the Binding Affinity of a Protein-Ligand Complex , 1998 .
[14] W. L. Jorgensen,et al. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. , 1988, Journal of the American Chemical Society.
[15] I. Longden,et al. EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.
[16] Z. Weng,et al. A structure‐based benchmark for protein–protein binding affinity , 2011, Protein science : a publication of the Protein Society.
[17] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[18] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[19] Olivier Sperandio,et al. Designing Focused Chemical Libraries Enriched in Protein-Protein Interaction Inhibitors using Machine-Learning Methods , 2010, PLoS Comput. Biol..
[20] David Ryan Koes,et al. PocketQuery: protein–protein interaction inhibitor starting points from protein–protein interaction structure , 2012, Nucleic Acids Res..
[21] Olivier Sperandio,et al. iPPI-DB: a manually curated and interactive database of small non-peptide inhibitors of protein-protein interactions. , 2013, Drug discovery today.
[22] William L. Jorgensen,et al. Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..
[23] Zhihai Liu,et al. Comparative Assessment of Scoring Functions on a Diverse Test Set , 2009, J. Chem. Inf. Model..
[24] Holger Gohlke,et al. The Amber biomolecular simulation programs , 2005, J. Comput. Chem..
[25] Alexandre M J J Bonvin,et al. HADDOCK versus HADDOCK: New features and performance of HADDOCK2.0 on the CAPRI targets , 2007, Proteins.
[26] David M. Wilson,et al. Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides. , 2012, Journal of medicinal chemistry.
[27] Haruki Nakamura,et al. Data Deposition and Annotation at the Worldwide Protein Data Bank , 2009, Molecular biotechnology.
[28] David Ryan Koes,et al. Small-molecule inhibitor starting points learned from protein–protein interaction inhibitor structure , 2011, Bioinform..
[29] Matteo Magnani,et al. Molecular Interaction Fields and 3D-QSAR Studies of p53-MDM2 Inhibitors Suggest Additional Features of Ligand-Target Interaction , 2010, J. Chem. Inf. Model..
[30] Arieh Warshel,et al. Absolute binding free energy calculations: On the accuracy of computational scoring of protein–ligand interactions , 2010, Proteins.
[31] D J Rogers,et al. A Computer Program for Classifying Plants. , 1960, Science.
[32] Gary D Bader,et al. The Genetic Landscape of a Cell , 2010, Science.
[33] Ruhong Zhou,et al. New Linear Interaction Method for Binding Affinity Calculations Using a Continuum Solvent Model , 2001 .
[34] R. Meadows,et al. Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.
[35] A. Barabasi,et al. Interactome Networks and Human Disease , 2011, Cell.
[36] Philippe Roche,et al. Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I). , 2011, Current opinion in chemical biology.
[37] P. Kastritis,et al. On the binding affinity of macromolecular interactions: daring to ask why proteins interact , 2013, Journal of The Royal Society Interface.
[38] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[39] Holger Gohlke,et al. How Good Are State-of-the-Art Docking Tools in Predicting Ligand Binding Modes in Protein-Protein Interfaces? , 2012, J. Chem. Inf. Model..
[40] Christus,et al. A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins , 2022 .
[41] A. W. Schüttelkopf,et al. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.
[42] M. Gilson,et al. Calculation of protein-ligand binding affinities. , 2007, Annual review of biophysics and biomolecular structure.
[43] Holger Gohlke,et al. Hot Spots and Transient Pockets: Predicting the Determinants of Small-Molecule Binding to a Protein-Protein Interface , 2012, J. Chem. Inf. Model..
[44] S. Srinivasula,et al. Mechanism of XIAP-mediated inhibition of caspase-9. , 2003, Molecular cell.
[45] Yanli Wang,et al. PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .
[46] R. Abagyan,et al. Identification of protein-protein interaction sites from docking energy landscapes. , 2004, Journal of molecular biology.
[47] Tjelvar S. G. Olsson,et al. The thermodynamics of protein-ligand interaction and solvation: insights for ligand design. , 2008, Journal of molecular biology.
[48] Philippe Derreumaux,et al. Flexibility and binding affinity in protein–ligand, protein–protein and multi-component protein interactions: limitations of current computational approaches , 2012, Journal of The Royal Society Interface.
[49] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[50] Grzegorz M. Popowicz,et al. Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists , 2012, PloS one.